Showing results (2391-2400 of 3,331) with videos related to
Sort By:
Pageof 334
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 24, 2004
[Study on AIDS related risk behaviors and the correlated factors among three groups of population in Sichuan province]Qiao Sun, Jian-xin Zhang, Xiao-song Li, et al.Yi Chuan = Hereditas|February 26, 2005
[Recognition and study of susceptible gene to ankylosing spondylitis]Xiao-Quan Zhu, Qing-Yu Zeng, Liang Sun, et al.Clinical Biochemistry|May 13, 2008
Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosusYih-Hsin Chang, I-Ling Lin, Gregory J Tsay, et al.Bioorganic & Medicinal Chemistry Letters|February 23, 2002
Structure-activity relationships of oxime neurokinin antagonists: oxime modificationsGregory A Reichard, James Spitler, Robert Aslanian, et al.Cardiovascular Diabetology|January 28, 2025
Does diabetes modify the triglyceride-glucose index associated with cardiovascular events and mortality? A meta-analysis of 50 cohorts involving 7,239,790 participantsJun Zhang, Qiye Zhan, Zhihao Deng, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 24, 2025
Vessel-On-A-Chip Coupled Proteomics Reveal Pressure-Overload-Induced Vascular RemodelingYanjun Liu, Jianxujie Zheng, Lingyan Zhong, et al.Cell Communication and Signaling : CCS|March 22, 2025
Platelet glycoprotein VI promotes folic acid-induced acute kidney injury through interaction with tubular epithelial cell-derived galectin-3Ya-Wei Guo, Qi Luo, Meng Lu, et al.BMC Cancer|September 28, 2024
Anlotinib plus oral fluoropyrimidine S-1 in refractory or relapsed small-cell lung cancer (SALTER TRIAL): a multicenter, single-arm, phase II trialWei Wang, Guixian Wu, Wujun Luo, et al.International Immunopharmacology|October 17, 2024
The VDR/FFAR2 axis mitigates sepsis-induced lung injury by suppressing macrophage lipid peroxidationFan Xu, Jia Xie, Weijiao Mou, et al.Journal of Global Health|February 20, 2025
The treatment responses among different inhalation therapies for GOLD group E patients with chronic obstructive pulmonary diseaseQing Song, Ling Lin, Tao Li, et al.Pageof 334